CLINICAL EVALUATION OF SULBACTAM/CEFOPERAZONE ON RESPIRATORY TRACT INFECTION

Abstract

Clinical study on sulbactam/cefoperazone (combined ratio 1: 1) was investigated in 25 patients with respiratory tract infections, and following results were obtained.
Clinical effects were Excellent in 19, Good in 5 and Poor in 1 patient and overall efficacy rate was 96%.
Bacteriological effects were investigated in 17 clinical isolated organisms and bacteriological efficacy rate was 88.2%.
During therapy drug fever and eosinophilia were observed in one patient.